NCT02498613 2025-09-25A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting122 enrolled 16 charts
NCT00244881 2015-12-07A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)National Cancer Institute (NCI)Phase 2 Completed26 enrolled 9 charts